Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams

Anxiety Clinical Trial

Official title:

Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams: A Randomized Controlled Trail

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06176924
• Other study ID #: SPC-PA-06
• Status: Recruiting
• Phase: N/A
• Start date: August 1, 2023
• Est. completion date: February 10, 2024

Study information

• Verified date: December 2023
• Source: Maharishi Markendeswar University (Deemed to be University)
• Contact: Rama Taneja
• Phone: 09518260372
• Email: ramataneja.055[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Anxiety is one of the most significant obstacles to academic success. When stress is interpreted negatively or becomes overwhelming, it causes anxiety before and during examinations, which in turn impacts students' academic performance. The difficulty in managing severely associated anxiousness enhances the demand for NIBS. It is a unique approach that has the potential to alleviate anxiety by modifying cortical excitability whereas Relaxation breaks the vicious cycle of pain caused by muscular stress, circulatory illness, and metabolic by-products alterations. The main purpose is to evaluate whether tDCS along with Relaxation technique reduces the anxiety level in competitive exam students. Total 46 students are recruited and randomly allocating in experimental and control group. The subjects in the experimental group are going to receive 9 tDCS sessions (2mA, anode placed on the DLFPC of left side and cathode on right supraorbital cortex for 20 min) along with relaxation technique. Subjects in the control group are going to receive 9 sessions of relaxation. The CSAI-2R scale is used as an Outcome Measure. Samples completed the CSAI-2R scale before and following the intervention. The data will be analyzed using SPSS 26.0 software.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 46
• Est. completion date: February 10, 2024
• Est. primary completion date: January 10, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years to 18 Years

Eligibility

Inclusion Criteria: • Both male and female students.

• Competitive Exam students only.

• Age group between 15 years to 18 years.

• Willingness to take part in the research.

Exclusion Criteria: • Seizure disorder

• Non-Corporative students

• Skin irritation

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders

Intervention

Device:
• tDCS
tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.

Other:
• Relaxation technique
Relaxation technique

Locations

Country	Name	City	State
India	MMIPR	Ambala	Haryana

Sponsors (1)

Lead Sponsor	Collaborator
Maharishi Markendeswar University (Deemed to be University)

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CSAI- 2R (Competitive State Anxiety Inventory-2R)	It is a reliable and viable scale for assessing the level of competitive anxiety. It's having 27 components, each having 4 grades ranging from 1 to 4.	5 minutes